HopkinsCFAR

Dr. Watson closes out the Bridging the Gap Symposium, presented by the JHU CFAR Community Participatory Advisory Board, with the important question: What do we do now? What steps make the most impact?

The Bridging the Gap Symposium, presented by the JHU CFAR Community Participatory Advisory Board, addresses Aging & Lived Experiences through personal stories of lifetime survivors

A big thank you to our panelists who spoke on “Street Medicine: Not Everyone is in a System” during the Bridging the Gap Symposium presented by the JHU CFAR Community Participatory Advisory Board!

The JHU CFAR Bridging the Gap Symposium, presented by the Community Participatory Advisory Board, is underway! The first panel is discussing Housing, Mental Health & Substance use

CDC Backs Twice-Yearly Injectable for HIV Prevention But clinical guidance won't necessarily equal insurance coverage

Hopkins CFAR Adolescent and Young Adult Scientific Working Group Co-Director, Dr. Allison Agwu quoted!

CDC Backs Twice-Yearly Injectable for HIV Prevention www.medpagetoday.com/infectiousdi...

‘HIV Unwrapped’ combines science and style for New York Fashion Week The floor was on fire when molecular structures met ballroom aesthetics and decades of scientific research to create colorful couture at "HIV Unwrapped," a

Co-Director of the Hopkins CFAR Lab Core, Deborah Persaud quoted, along with our beloved former co-director, Chris Beyrer
gaycitynews.com/hiv-unwrappe...

Join us on 24 Hours to Save AIDS Research NOW to hear about the incredible successes of the NIH-funded HIV research networks, with leaders Myron Cohen, Larry Corey, Joseph Eron, and Sharon Nachman on YouTube: bit.ly/45Qftts #saveAIDSresearch #HIV

24 Hours to Save AIDS Research is an all-day, online marathon that will include >70 speakers from around the world, enabling people from all time zones to access the programming in real time. Join us! Register bit.ly/45U1keO and join us on YouTube bit.ly/45Qftts. #HIV #saveAIDSresearch #HIVresearch

Check out the CFAR September Newsletter!
mailchi.mp/mail465.jh.e...

Save the Date! Please join the Center for AIDS Research on Friday, September 26th for the CFAR Annual Meeting!

Persistence is Resistance: The fight to End the HIV Epidemic Hangs in the Balance In this perspective piece, representatives from the HIV Medicine Association urge persistent advocacy to resist harmful federal policies to the field of HI

📚Publication: In this perspective piece, representatives from the #HIV Medicine Association urge persistent advocacy to resist harmful federal policies to the field of HIV medicine, research, public health, and the communities we serve

Both regimens of HepB-CpG vaccine achieved a superior seroprotection response compared with 3 doses of HepB-alum vaccine, potentially offering PWH better protection against HBV infection

In a phase 3 clinical trial, PWH with nonresponse to prior hepatitis B vaccination were randomly assigned to receive 2 doses of HepB-CpG vaccine or 3 doses of HepB-alum vaccine of HepB-alum vaccine.

Nonresponse to hepatitis B vaccine is common among people with HIV (PWH), resulting in hepatitis B virus (HBV) vulnerability.

HepB-CpG vs HepB-Alum Vaccine in People With HIV and Prior Vaccine Nonresponse This randomized clinical trial compares the seroprotection response achieved with a 2-dose and a 3-dose hepatitis B vaccine with a cytosine phosphoguanine adjuvant vs a conventional 3-dose hepatitis B...

📚Publication: The BEe-HIVe Randomized Clinical Trial. Check out the comments for more details!

<em>Journal of the International AIDS Society</em> | IAS HIV Research Journal | Wiley Online Library Introduction The “Universal Test and Treat” (UTT) era for antiretroviral therapy (ART) increased HIV service delivery to children and adolescents aged 0–19 with HIV. The goal is to reach ≥95% of peo...

📚Publication: Characterizing the #HIV care continuum among children and adolescents with HIV in eastern and southern Africa in the era of “Universal Test and Treat”: A systematic review and meta‐analysis onlinelibrary.wiley.com/doi/10.1002/...

Check out the JHU Center for AIDS Research June Newsletter! mailchi.mp/mail465.jh.e...

IAS 2025, the 13th IAS Conference on HIV Science | IAS 2025

👥 Join thousands of #HIV researchers, advocates, policy makers and community leaders at #IAS2025, which kicks off 13 July in #Kigali and virtually!

✅ Register today and help shape the future of the HIV response!

📚Publications: New #ImpSci research alert! The April 2025 JAIDS supplemental issue compiles
findings from 120 NIH-funded #EHE projects, providing a roadmap for scaling up #HIV
interventions and accelerating progress toward ending the HIV epidemic by 2030

Check out the JHU Center for AIDS Research April Newsletter! mailchi.mp/mail465.jh.e...

"The expiration of PEPFAR's reauthorization is more than a bureaucratic setback: It marks a pivotal moment for the future of the global HIV response," @jirairratevosian.bsky.social writes in this must-read piece.

📚Publication: Tuberculosis disease among people with HIV: therapeutic advances, led by Vidya Mave, has just been published in Lancet HIV for #WorldTBDay! #TB #HIV
authors.elsevier.com/c/1kpVX8MsVo...

Join us on 4/3 @noon for the CFAR Prevention Core Event, "From Slim Disease to the Threshold of #HIV Control: Four Decades of Interdisciplinary Research at the Rakai Health Sciences Program." Register to join: www.surveymonkey.com/r/MVCRX57

Two More People May Be Cured of HIV After Stem Cell Transplants One experienced viral rebound after an initial treatment interruption but remains in remission after stopping antiretrovirals a second time.

News from #CROI2025: Two more people appear to be free of HIV after stem cell transplants for cancer treatment. If these men remain in remission, they will be the 8th & 9th known cases of a functional cure after the procedure.

www.poz.com/article/two-...

We had a marathon meeting for our Lancet HIV Commission on Aging with HIV today in San Francisco.

Our team of experts for this commission work are the very BEST!

And this evening kicked off #CROI2025!

Strengthening HIV control efforts may be essential for improving TB treatment success in this population

📚Publication: Addressing both #TB and #HIV in #pregnancy is critical for maternal health. #NataliaHernandez-Morfin et al. analysis of the Tshepiso study reveals that a detectable HIV viral load at diagnosis is a key factor linked to unsuccessful TB treatment outcomes in pregnant women...

aidsmap returns with reporting from the Conference on Retroviruses and Opportunistic Infections (CROI) News reporting by aidsmap will be restarting next week, under the new stewardship of Terrence Higgins Trust.

www.aidsmap.com/news/mar-202...